top of page

The clinical trial for MPS II gene therapy is expected to start by the end of 2017. Since Nationwide Children’s Hospital is a public service, it relies heavily on patient parent funding. The MPS II community needs to raise $2.5 Million to manufacture the vector and fund the Phase I trial.

Project Alive is a 501(c)(3) non-profit organization dedicated to cure Hunter Syndrome / Mucopolysaccharidosis II through research and advocacy. It is parent funded and 100% contributions go towards MPS II gene therapy research. (IRS Tax ID# 46-4617970). Donate in honor of Noah Nguyen at

Together was can make this happen. Thank you. God bless.

How You Can Help

PayPal ButtonPayPal Button

via Paypal


Contributions for Medical Expenses

Support Research for a Cure

(Preferred Option)

bottom of page